Skip to content

PTCT

PTC Therapeutics, Inc.

Key figures

MetricLast 12 months5-year CAGR
Revenue$1.2B+35.4%
Gross profit$938M+36.0%
Operating income$148M—
Net income−$106M—
EPS−$1.05—
Free cash flow$2.1M—